Suppr超能文献

每日服用150微克甲状腺素以预防甲状腺肿复发

[Thyroxine in an amount of 150 micrograms daily for the prevention of the recurrence of goiter].

作者信息

Goebel R, Leb G, Warnkross H, Köle W

出版信息

Acta Med Austriaca. 1977;4(5):203-6.

PMID:613702
Abstract

24 patients, who had undergone a subtotal thyroidectomy, were given 150 micrograms thyroxine daily for 6 weeks for prevention of goiter recurrency. 14 patients had been included in an earlier reported study using 75 micrograms thyroxine daily. Prior to this trial 10 patients had 100 micrograms thyroxine daily; the 14 above mentioned patients had had no therapy for 4 weeks. A significant decrease of the TSH response to TRH is observed when compared with the prestudy regimen. According to this parameter the incidence of hyperthyroidism is increased and the incidence of euthyroidism and hypothyroidism decreased. 2 patients however remained hypothyroid. The before mentioned hyperthyroid patients had only an abnormal TSH-response and were euthyroid when determined by clinical signs or ETR-values. It is concluded, that the dosage of 150 micrograms thyroxin is indicated in patients when reduction of goiter size is desired or a high demand for thyroid replacement is suspected. This (and every comparable) regimen needs a clinical and biochemical control.

摘要

24例行甲状腺次全切除术的患者,为预防甲状腺肿复发,每天给予150微克甲状腺素,持续6周。14名患者曾纳入一项先前报道的研究,该研究中患者每天服用75微克甲状腺素。在本次试验之前,10名患者每天服用100微克甲状腺素;上述14名患者有4周未接受治疗。与研究前的治疗方案相比,促甲状腺激素(TSH)对促甲状腺激素释放激素(TRH)的反应显著降低。根据该参数,甲状腺功能亢进的发生率增加,甲状腺功能正常和甲状腺功能减退的发生率降低。然而,有2名患者仍为甲状腺功能减退。上述甲状腺功能亢进患者仅TSH反应异常,根据临床体征或促甲状腺激素释放激素兴奋试验(ETR)值判断时,甲状腺功能正常。得出的结论是,当希望缩小甲状腺肿大小或怀疑对甲状腺替代有高需求时,患者应使用150微克甲状腺素的剂量。这种(以及每一种类似的)治疗方案都需要临床和生化监测。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验